Microbiome Drug Development Summit Europe Paris 2018: Paris, France, 29 January - 1 February, 2018
Microbiome Drug Development Summit Europe Paris 2018

Microbiome Drug Development Summit Europe Paris 2018

Paris, France
29 January - 1 February, 2018

Situated at the heart of therapeutic R and D, the Microbiome Drug Development Summit kick starts 2018, once again to help large pharma, biotech and academic institutions accelerate the discovery, clinical development of safe, effective and commercially scalable microbiome therapeutics across a broad range of disease indications.

Brochure: https://go.evvnt.com/160058-0
Booking: https://go.evvnt.com/160058-1

Industry Conference Only: EUR 2199,
Academic Conference Only: EUR 1699.

Speakers: Outi Vaarala (VP Head of Translational Biology at AstraZeneca), Olga Danilchanka (Microbiome Lead; Exploratory Science Center (ESC) at Merck), Laurence Zitvogel (Professor at Institut Gustave Roussy), Lee Jones (CEO at Rebiotix), Kristin Wannerberger (Director RandD Alliance Management at Ferring Pharmaceuticals), John Aunins (EVP of Manufacturing and Chief Technology Officer at Seres Therapeutics), Jim Brown (Director Computational Biology at GSK), Daniel van der Lelie (Chief Scientific Officer at Gusto Global), Christian Freguia (Director of Research at Synthetic Biologics).

Time: 8:00 am to 6:00 pm.

Category:Science, Health and Medicine
Leave a Comment
Full Name:
E-mail Address: